|
|
 |
 |
| Sunday, 22 February 2004 |
 |
|
 |
Business |  |
| News Business Features Editorial
|
Traitorous bacteria to cure bowel disease Bifilac is a new pharmaceutical product that can be used as a preventive and/or a curative, as treatment for many gastrointestinal disorders. Bifilac is the first symbiotic of its kind in Sri Lanka that was launched recently. That bacteria in fermented products have been competing with microorganisms that are injurious to health was clearly established over a century ago on the basis of research conducted by the Russian immunologist Nobel Laureate Prof. Elie Metchinkoff, who argued that life-long intake of yoghurt containing lactic acid producing microorganisms could explain the differences in lifespan between ethnic groups. Bifilac is the result of long-term research and development efforts epicentred in Japan that has converted bad bacteria through mutations to good bacteria. It is now used as a traitor to fight bad bacteria. Bifilac has properties to correct antibiotic-induced diarrhoea and restore "the inner rain forests" of the human gastro-intestinal eco system. Bifilac stimulates intestinal immunity and can correct a host of gastrointestinal problems like constipation, diarrhoea, irritable bowel syndrome, mouth ulcers and so on, if taken regularly. The unique feature of Bifilac unlike common probiotic, is that it works at different levels of the human digestive tract through raising the counts of Lactobacillus in the small intestines and bifidobacterial counts in the colon. This special probiotic is available in capsules and sachets for oral use in adults and children. Regular use of Bifilac - Promotes digestive health and bowel habits Clears intestines of Toxins, waste and harmful bacteria. Promotes clearer complexion Aids body's natural defence. Bifilac is the engine that powers gut health. |
|
News | Business | Features
| Editorial | Security Produced by Lake House |
